Back to search
Neuromuscular Blockade Reversal Agent
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neuromuscular Blockade Reversal Agent trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Neuromuscular Blockade Reversal Agent trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Study Objective: This study aims to evaluate the incidence, severity, and risk factors of sugammadex-induced mouth clenching during neuromuscular blockade (NMB…
This study will compare how two drugs, sugammadex and neostigmine-used to reverse muscle relaxation after surgery-affect the size of the optic nerve sheath (the…
Background context: Amogammadex sodium has completed Phase I-III clinical studies in China for reversal of rocuronium-induced blockade. No clinical studies have…
Sugammadex is a drug used more and more frequently in infants as a rocuronium' s reversal agent. It has multiples benefits over other reversal agents such as a…